Breakthrough T1D Children’s Congress Starts Next Week
Event Unites T1D Celebrities and Youth with Congressional Leadership We are just days away from one of Breakthrough T1D’s most…
Breakthrough T1D Urges Congress to Fund Diabetes Research
On June 4, Breakthrough T1D’s President & CEO Aaron J. Kowalski, Ph.D., testified before the U.S. House of Representatives Committee…
Pump Choice Should Be in the Hands of Those with T1D, NOT Health Insurance Plans
As many of you know, UnitedHealthcare (UHC) has limited insulin pump choice for children and adults through a new policy…
Testimony of Dr. Aaron Kowalski, Chief Mission Officer, Breakthrough T1D House Energy & Commerce Committee Oversight And Investigations Subcommittee
‘PRICED OUT OF A LIFESAVING DRUG: THE HUMAN IMPACT OF RISING INSULIN COSTS’ Chairwoman DeGette, Ranking Member Guthrie, Chairman Pallone,…
Send a Letter to the Administration to Help Lower Insulin Prices
Earlier this year, the U.S. Department of Health and Human Services (HHS) announced a proposal to lower prescription drug prices and out-of-pocket…
Advocacy in Action: Breakthrough T1D 2019 Government Day
After nearly 500 meetings with Members of Congress, Breakthrough T1D 2019 Government Day has officially come to a close. Over…
Eli Lilly Announces Lower-Cost Generic Insulin
Eli Lilly and Company announced it will begin selling a generic version of its most commonly prescribed insulin -- Humalog
We’re the Advancing Progress Type
Breakthrough T1D Fiscal Year 2018 Annual Report As you’ll see in the pages of our fiscal year 2018 annual report,…
In a Step Backward, UnitedHealthcare Changes Policy to Limit Insulin Pumps for Children
On February 1, 2019, UnitedHealthcare (UHC) announced a significant change to its insulin pump coverage policy, as it will no…
An Important Step in the FDA Review of Sotagliflozin (Zynquista™) for T1D
You’ll hear it again and again: For some people with type 1 diabetes (T1D), SGLT inhibitor therapy* means taking less…
